Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Notes Payables (2018 - 2025)

Updated

Sinovac Biotech's Notes Payables came in at $229.37 million for Q4 2025, up 8.2% from $211.92 million a year earlier.

Analysis

Sinovac Biotech (SVA) Notes Payables (2018 - 2025) Analysis & Trends

Going back to Q4 2018, Sinovac Biotech's Notes Payables data covers 8 quarters.

  • Notes Payables carries a five-year compound annual growth rate of 47.4% (FY2020 to FY2025).
  • Going back by year, Notes Payables was $211.92 million in FY2024 (+178.5%), $76.09 million in FY2023, $293,000 in FY2022 (-90.5%) and $3.1 million in FY2021 (-90.6%).
  • The Q4 2025 figure represents the highest quarterly Notes Payables in data going back to Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Sinovac Biotech 464.94 Mn -35.05 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 229.37 Mn
Dec 31, 2024 211.92 Mn
Dec 31, 2023 76.09 Mn
Dec 31, 2022 293,000.00
Dec 31, 2021 3.10 Mn
Dec 31, 2020 32.94 Mn
Dec 31, 2019 5.93 Mn
Dec 31, 2018 3.32 Mn
API Access

Sinovac Biotech Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=SVA&period=max&api_key=YOUR_API_KEY